Treatment of poly cystic ovarian syndrome.
Phase 2
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201405082624N15
- Lead Sponsor
- Vice chancellor for research ,Iran University of Medical Sciences.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
20-36 years old; having poly cystic ovarian syndrome; (Rotterdam society criteria : 2 of 3; having 2 out of 3 criteria including oligo or anovulation, hyperandrogenemia, or hyperandrogenism, poly cystic ovaries in ultrasound).
Exclusion criteria: known other systemic and metabolic disorders; congenital adrenal hyperplasia; Cushing syndrome; androgen producing tumors; hyperprolactinemia; hypo or hyper thyroidism; diabetes mellitus; history of peptic ulcer; any other drug use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the menstrual cycle. Timepoint: Monthly. Method of measurement: Data sheets.
- Secondary Outcome Measures
Name Time Method Change in weight. Timepoint: 24 weeks. Method of measurement: data sheets.;Change in body mass index. Timepoint: 24 weeks. Method of measurement: data sheets.;Fasting blood sugar. Timepoint: 24 weeks. Method of measurement: data sheets.;Serum insulin. Timepoint: 24 weeks. Method of measurement: data sheets.;Change in low density lipoprotein. Timepoint: 24 weeks. Method of measurement: data sheets.;Change in HOMA index. Timepoint: 24 weeks. Method of measurement: data sheets.;Change in high density lipoprotein. Timepoint: 24 weeks. Method of measurement: data sheets.